Your browser does not fully support modern features. Please upgrade for a smoother experience.
Subject:
All Disciplines Arts & Humanities Biology & Life Sciences Business & Economics Chemistry & Materials Science Computer Science & Mathematics Engineering Environmental & Earth Sciences Medicine & Pharmacology Physical Sciences Public Health & Healthcare Social Sciences
Sort by:
Most Viewed Latest Alphabetical (A-Z) Alphabetical (Z-A)
Filter:
All Topic Review Biography Peer Reviewed Entry Video Entry
Topic Review
Oxidative Stress, NAD+ in ASL
ALS, often referred to as “Lou Gehrig’s disease”, is a progressive neurodegenerative disease that damages motor neurons (MNs) in the brain and the spinal cord. This loss of MNs is responsible for progressive weakness and paralysis. There is mounting evidence involving oxidative stress as a main pathophysiological mechanism leading to MN damage and death. Conceptually, oxidative stress is an imbalance of oxygen-derived free radicals and antioxidants in the body, which can lead to cell and organ damage. Reactive oxygen species (ROS) contain an uneven number of electrons and, at high non-physiological levels, can cause oxidative damages to nucleic acids, lipids, and proteins. Moreover, the generation of NO and H2O2 (induced by proinflammatory cytokines in e.g., endothelial cells) can lead to the formation of highly damaging –OONO radicals. On the other hand, NAD+ is involved in cell bioenergetics, redox regulation, signaling, homeostasis, adaptive response to stress, and survival. Specifically, different NAD+-dependent enzymes are implicated in mechanisms regulating synaptic plasticity and neuronal resilience to stress.
  • 1.3K
  • 03 Sep 2021
Topic Review
Flavonoids Synergistically Enhance Anti-Glioblastoma Effects of Chemotherapeutic Drugs
Flavonoids are polyphenolic plant secondary metabolites with pleiotropic biological properties, including anti-cancer activities. These natural compounds have potential utility in glioblastoma (GBM), a malignant central nervous system tumor derived from astrocytes. 
  • 1.3K
  • 16 Dec 2021
Topic Review
Sleep-Related Dissociative States
Sleep is not only a whole-brain process but also a complex local phenomenon controlled by specific neurotransmitters that act in different neural networks, which is called “local sleep”. Moreover, the basic states of human consciousness - wakefulness, sleep onset (N1), light sleep (N2), deep sleep (N3), and rapid eye movement (REM) sleep - can concurrently appear, which may result in different sleep-related dissociative states.
  • 1.3K
  • 05 Jul 2023
Topic Review
Nitrooxidative Stress and Neuroinflammation Caused by Air Pollutants
Millions of people around the world are exposed to air pollutants, such as particulate matter 2.5 (PM2.5) and ozone (O3). Such exposure usually does not exclude these two types of pollutants and their harmful effects could be additive or synergistic. O3 is a highly oxidizing gas that reacts with the cellular environment just as PM2.5, triggering nitrooxidative damage.
  • 1.3K
  • 13 Mar 2024
Topic Review
Neuronal Autophagy in Ageing
Autophagy plays critical roles in development, maintenance and survival of distinct cell populations including neurons. 
  • 1.3K
  • 19 Aug 2021
Topic Review
Neuroprotection and Non-Invasive Brain Stimulation
Non-Invasive Brain Stimulation (NIBS) techniques, such as transcranial Direct Current Stimulation (tDCS) and repetitive Magnetic Transcranial Stimulation (rTMS), are well-known non-pharmacological approaches to improve both motor and non-motor symptoms in patients with neurodegenerative disorders. Their use is of particular interest especially for the treatment of cognitive impairment in Alzheimer’s Disease (AD), as well as axial disturbances in Parkinson’s (PD), where conventional pharmacological therapies show very mild and short-lasting effects. However, their ability to interfere with disease progression over time is not well understood; recent evidence suggests that NIBS may have a neuroprotective effect, thus slowing disease progression and modulating the aggregation state of pathological proteins. 
  • 1.3K
  • 23 Nov 2022
Topic Review
Sleep in Disorders of Consciousness
Consciousness is a multifaceted concept, involving both wakefulness, i.e., a condition of being alert that is regulated by the brainstem, and awareness, a subjective experience of any thoughts or perception or emotion. Disorders of consciousness (DOC) are usually caused by a severe acquired brain injury that leads to a loss of consciousness lasting at least 24 h. The management of sleep disorders in DOC patients is an increasingly hot topic and deserves careful diagnosis, to allow for the most accurate prognosis and the best medical treatment possible.
  • 1.3K
  • 23 Feb 2023
Topic Review
Bioflavonoids for Targeting Gut Microbiome in Alzheimer’s Disease
Alzheimer’s Disease (AD), the most common type of dementia, is known as a neurodegenerative disease caused by the accumulation of amyloid beta (Aβ) peptides and tau protein hyperphosphorylation resulting in the formation of neurofibrillary tangles, activation of inflammasomes, sluggish autophagy, and neuronal loss. Several of these hallmarks are linked to alteration in the gut microbiome, also known as gut dysbiosis. Selective bioflavonoids can target gut microbiome to inhibit inflammasomes and resume autophagy to stop AD pathogenesis. Two bioflavonoids, specifically epigallocatechin-3-gallate (EGCG) and genistein (GS), appear to be a new paradigm of treatment for maintaining healthy gut microbiome in AD via modulating crucial AD signaling pathways.
  • 1.3K
  • 03 Mar 2024
Topic Review
Adulthood ADHD and Bipolar Disorder
Attention deficit hyperactivity disorder (ADHD) is a condition that usually has its onset in childhood. Although the disorder persists into adulthood in half of cases, adult ADHD is often not recognized due to different psychopathological characteristics, quite often overlapping with other diagnoses such as mood, anxiety and personality disorders. This is especially true for bipolar disorder (BD), which shares several symptoms with adult ADHD. Moreover, besides an overlapping clinical presentation, BD is often co-occurring in adults with ADHD, with comorbidity figures as high as 20%. 
  • 1.3K
  • 28 Jun 2021
Topic Review
Alpha-Synuclein
Alpha-Synuclein (α-syn) has strong connection with Parkinson’s disease. Parkinson’s disease (PD) is considered the most common disorder of synucleinopathy, which is characterised by intracellular inclusions of aggregated and misfolded α-syn protein in various brain regions, and the loss of dopaminergic neurons. During the early prodromal phase of PD, synaptic alterations happen before cell death, which is linked to the synaptic accumulation of toxic α-syn specifically in the presynaptic terminals, affecting neurotransmitter release. The oligomers and protofibrils of α-syn are the most toxic species, and their overexpression impairs the distribution and activation of synaptic proteins, such as the SNARE complex, preventing neurotransmitter exocytosis and neuronal synaptic communication. In the last few years, the role of the immune system in PD has been increasingly considered. Microglial and astrocyte activation, the gene expression of proinflammatory factors, and the infiltration of immune cells from the periphery to the central nervous system (CNS) represent the main features of the inflammatory response. One of the actors of these processes is α-syn accumulation.
  • 1.3K
  • 29 Jun 2021
Topic Review Video
Mild-to-Moderate Traumatic Brain Injury
Traumatic Brain Injury (TBI) is a major global public health problem. Neurological damage from TBI may be mild, moderate, or severe and occurs both immediately at the time of impact (primary injury) and continues to evolve afterwards (secondary injury). In mild (m)TBI, common symptoms are headaches, dizziness, and fatigue. Visual impairment is especially prevalent. Insomnia, attentional deficits and memory problems often occur. While symptoms resolve spontaneously in many, residual effects may linger for months or years in some mTBI patients. Optimally, the goal of any intervention is a return to baseline uninjured functioning with restoration of the ability to conduct daily activities.  
  • 1.3K
  • 16 Jun 2022
Topic Review
Sympathetic Activation after Myocardial Infarction
Myocardial infarction often leads to progressive structural and electrophysiologic remodeling of the left ventricle. Histological and functional studies have demonstrated extensive alterations of sympathetic nerve endings at the peri-infarct area and flow-innervation mismatches that create a highly arrhythmogenic milieu.
  • 1.3K
  • 26 Jun 2021
Topic Review
Amyloid Beta (Aβ) Formation
One of the prime suspects in AD pathology, β-amyloid is a major component of amyloid senile plaques derived from the proteolytic action of proteases such as β-secretase and γ-secretase on amyloid-β precursor protein (APP).
  • 1.3K
  • 30 Dec 2021
Topic Review
Optic Flow in Postural Control
Optic flow stimuli are crucial for the control of stance in the upright position. The visual control of posture has recently received a lot of interest from several researchers. One of the most intriguing aspects is the contribution of the different parts of the visual field in the control of stance.
  • 1.3K
  • 17 Jun 2021
Topic Review
Pathomechanisms for GABRG2 and GABRB3 Mutations in DEEs
GABAA receptor genes (GABR) are a group of genes associated with DEE, although previous studies have been focused on relatively mild epileptic syndromes, such as childhood absence epilepsy (CAE), febrile seizures (FS), and generalized tonic-clonic seizures with febrile seizure plus (GEFS+). Mutations in GABAA receptor subunit genes (GABRs) are a major etiology for developmental and epileptic encephalopathies (DEEs).
  • 1.3K
  • 15 Sep 2022
Topic Review
Neurotherapeutics for Attention Deficit/Hyperactivity Disorder
Attention-deficit/hyperactivity disorder (ADHD) is characterised by persisting and impairing symptoms of age-inappropriate inattention and/or hyperactivity/impulsivity (DSM-5). EEG-neurofeedback has been tested for about 45 years, with the latest meta-analyses of randomised controlled trials (RCT) showing small/medium effects compared to non-active controls only. Three small studies piloted neurofeedback of frontal activations in ADHD using functional magnetic resonance imaging or near-infrared spectroscopy, finding no superior effects over control conditions. Brain stimulation has been applied to ADHD using mostly repetitive transcranial magnetic and direct current stimulation (rTMS/tDCS). rTMS has shown mostly negative findings on improving cognition or symptoms. Meta-analyses of tDCS studies targeting mostly the dorsolateral prefrontal cortex show small effects on cognitive improvements with only two out of three studies showing clinical improvements. Trigeminal nerve stimulation has been shown to improve ADHD symptoms with medium effect in one RCT. Modern neurotherapeutics are attractive due to their relative safety and potential neuroplastic effects. However, they need to be thoroughly tested for clinical and cognitive efficacy across settings and beyond core symptoms and for their potential for individualised treatment.
  • 1.3K
  • 28 Mar 2022
Topic Review
Astrocytic GABAergic Regulation in Alcohol Use
Gamma-aminobutyric acid (GABA) is the major inhibitory neurotransmitter in the central nervous system (CNS). Most GABAergic neurons synthesize GABA from glutamate and release it in the synaptic cleft in the CNS. However, astrocytes can also synthesize and release GABA, activating GABA receptors in the neighboring neurons in physiological and pathological conditions. As the primary homeostatic glial cells in the brain, astrocytes play a crucial role in regulating GABA homeostasis and synaptic neurotransmission. Accumulating evidence demonstrates that astrocytic GABA dysregulation is implicated in psychiatric disorders, including alcohol use disorder (AUD) and major depressive disorder (MDD), the most prevalent co-occurring psychiatric disorders. 
  • 1.3K
  • 20 Feb 2024
Topic Review
Trace Elements on Glaucomatous Diseases
Glaucoma is a heterogeneous group of chronic neurodegenerative disorders characterized by a relatively selective, progressive damage to the retinal ganglion cells (RGCs) and their axons, which leads to axon loss and visual field alterations. To date, many studies have shown the role of various elements, mainly metals, in maintaining the balance of prooxidative and antioxidative processes, regulation of fluid and ion flow through cell membranes of the ocular tissues. Based on the earlier and current research results, their relationship with the development and progression of glaucoma seems obvious and is increasingly appreciated.
  • 1.3K
  • 27 Apr 2021
Topic Review
Neuroplasticity in Development, Aging, and Neurodegeneration
Neuroplasticity refers to the ability of the brain to reorganize and modify its neural connections in response to environmental stimuli, experience, learning, injury, and disease processes. It encompasses a range of mechanisms, including changes in synaptic strength and connectivity, the formation of new synapses, alterations in the structure and function of neurons, and the generation of new neurons.
  • 1.3K
  • 29 Nov 2023
Topic Review
The Molecular Mechanisms of 4-N-[2-(4-Phenoxyphenyl)Ethyl]Quinazoline-4,6-Diamine Activity
Quinazoline derivatives are a large pool of natural and synthetic compounds. The first derivatives of quinazoline were synthesized at the end of the 19th century. one quinazoline derivative (4-N-[2-(4-phenoxyphenyl)ethyl]quinazoline-4,6-diamine)—EVP4593 (also marked as QNZ) was originally synthesized in 2003 as a modulator of the nuclear factor kappa B (NF-κB) signal transduction pathway. Since that time, EVP4593 has been widely used as a blocker of NF-κB signaling (Sigma-Aldrich, cat #481417). Further it has been reported the ability of EVP4593 to affect store-operated calcium channels.
  • 1.3K
  • 21 Dec 2022
  • Page
  • of
  • 54
Academic Video Service